PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc., a leading provider of agentic AI in drug development, today announced it is bringing agentic AI to Alveus Therapeutics, a clinical-stage biotech developing next-generation medicines for obesity and metabolic disease. The Clinical Oversight Agent is intended to support the review of clinical development information by the Alveus clinical team.Through Medable’s Agentic Accelerator Program, Medable’s Forward Deployed Engineers (FDEs) work alongside

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.